Autologous pancreatic islet transplantation in human bone marrow

Diabetes

Volumn 62, Issue 10, 2013, Pages 3523-3531

  Maffi, Paola ^a   Balzano, Gianpaolo ^a   Ponzoni, Maurilio ^a   Nano, Rita ^a   Sordi, Valeria ^a   Melzi, Raffaella ^a   Mercalli, Alessia ^a   Scavini, Marina ^a   Esposito, Antonio ^a   Peccatori, Jacopo ^a   Cantarelli, Elisa ^a   Messina, Carlo ^a   Bernardi, Massimo ^a   Del Maschio, Alessandro ^a,b   Staudacher, Carlo ^a,b   Doglioni, Claudio ^a,b   Ciceri, Fabio ^a   Secchi, Antonio ^a,b   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; BONE MARROW BIOPSY; BONE STRUCTURE; CASE REPORT; ENGRAFTMENT; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; ILIAC CREST; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MORPHOLOGY; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PILOT STUDY; PRIORITY JOURNAL; DIABETES MELLITUS, TYPE 1; EVALUATION STUDY; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; BONE MARROW; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATECTOMY; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84891494667     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0465     Document Type: Article

References (39)

1. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012;35:1436-1445
2. Toyofuku A, Yasunami Y, Nabeyama K, et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006;55: 34-39
3. Yasunami Y, Kojo S, Kitamura H, et al. Valpha14 NK T cell-triggered IFNgamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005;202:913-918
4. Citro A, Cantarelli E, Maffi P, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Invest 2012;122:3647-3651
5. Korsgren O, Lundgren T, Felldin M, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 2008;51: 227-232
6. Desai NM, Goss JA, Deng S, et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 2003;76:1623-1625
7. Shapiro AM, Gallant HL, Hao EG, et al. The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit 2005;27:35-37
8. Bhargava R, Senior PA, Ackerman TE, et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004;53:1311-1317
9. Piemonti L, Everly MJ, Maffi P, et al. Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 2013;62:1656-1664
10. Piemonti L, Guidotti LG, Battaglia M. Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes. Adv Exp Med Biol 2010;654:725-747
11. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045
12. Eich T, Eriksson O, Lundgren T; Nordic Network for Clinical Islet Transplantation. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007; 356:2754-2755
13. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005;77:587-597
14. Eriksson O, Eich T, Sundin A, et al. Positron emission tomography in clinical islet transplantation. Am J Transplant 2009;9:2816-2824
15. Crowe LA, Ris F, Nielles-Vallespin S, et al. A novel method for quantitative monitoring of transplanted islets of langerhans by positive contrast magnetic resonance imaging. Am J Transplant 2011;11:1158-1168
16. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999;48:1907-1914
17. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54:1755-1762
18. Sakata N, Hayes P, Tan A, et al. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation 2009;87:825-830
19. Yin D, Ding JW, Shen J, Ma L, Hara M, Chong AS. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant 2006;6:60-68
20. Barshes NR, Lee TC, Goodpastor SE, et al. Transaminitis after pancreatic islet transplantation. J Am Coll Surg 2005;200:353-361
21. Rafael E, Ryan EA, Paty BW, et al. Changes in liver enzymes after clinical islet transplantation. Transplantation 2003;76:1280-1284
22. Casey JJ, Lakey JR, Ryan EA, et al. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation 2002;74: 913-915
23. Morrison CP, Wemyss-Holden SA, Dennison AR, Maddern GJ. Islet yield remains a problem in islet autotransplantation. Arch Surg 2002;137: 80-83
24. Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep 2011;11:364-374
25. Ciceri F, Piemonti L. Bone marrow and pancreatic islets: an old story with new perspectives. Cell Transplant 2010;19:1511-1522
26. Cantarelli E, Melzi R, Mercalli A, et al. Bone marrow as an alternative site for islet transplantation. Blood 2009;114:4566-4574
27. Melzi R, Mercalli A, Sordi V, et al. Role of CCL2/MCP-1 in islet transplantation. Cell Transplant 2010;19:1031-1046
28. Frassoni F, Gualandi F, Podestà M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008;9:831-839
29. Caumo A, Maffi P, Nano R, et al. Comparative evaluation of simple indices of graft function after islet transplantation. Transplantation 2011; 92:815-821
30. Mercalli A, Sordi V, Ponzoni M, et al. Rapamycin induces a caspaseindependent cell death in human monocytes. Am J Transplant 2006;6: 1331-1341
31. Bassi C, Dervenis C, Butturini G, et al.; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13
32. Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation. Transplantation 2009;88:1286-1293
33. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 2004;47:597-613
34. Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973;9:486-491
35. Scharp DW, Lacy PE, Santiago JV, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990;39:515-518
36. Rafael E, Tibell A, Rydén M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008;8:458-462
37. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25 +FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006;177:8338-8347
38. Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 2012;307:1169-1177
39. Piatti PM, Pontiroli AE, Caumo A, et al. Hyperinsulinemia decreases secondphase but not first-phase arginine-induced insulin release in humans. Diabetes 1994;43:1157-1163